Eledon Pharmaceuticals
ELDN
ELDN
85 hedge funds and large institutions have $111M invested in Eledon Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less capital invested
Capital invested by funds: $130M → $111M (-$19.7M)
40% less call options, than puts
Call options by funds: $134K | Put options by funds: $223K
Holders
85
Holding in Top 10
1
Calls
$134K
Puts
$223K
Top Buyers
| 1 | +$7.81M | |
| 2 | +$2.15M | |
| 3 | +$1.18M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.1M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$970K |
Top Sellers
| 1 | -$1.92M | |
| 2 | -$1.7M | |
| 3 | -$1.47M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.04M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$961K |